-
Big Movers: Oracle Corporation (NYSE:ORCL), Schlumberger Limited (NYSE:SLB), SouFun Holdings (NYSE:SFUN), PDL BioPharma (NASDAQ:PDLI), Theravance Biopharma (NASDAQ:TBPH)
Oracle Corporation (NASDAQ:ORCL) CEO Mark V. Hurd sold 375,000 shares of the company’s stock on the open market in a transaction dated Friday, January 2nd. The shares were sold at an average price of $44.57, for a total value of $16,713,750.00. Following the completion of the transaction, the chief executive officer now directly owns 1,000…
-
Investors Are Eying: Pfizer Inc. (NYSE:PFE), Ford Motor Company (NYSE:F), Theravance Biopharma (NASDAQ:TBPH), American Realty Capital Properties (NASDAQ:ARCP), Midstates Petroleum (NYSE:MPO)
U.S. Pfizer Inc. (NYSE:PFE) is unlikely to come back with a fresh bid for AstraZeneca, the Anglo-Swedish pharmaceuticals group’s top executive was quoted as saying by Swedish business daily Dagens Industri on Dec, 20. Pfizer Inc. (NYSE:PFE) in last trading activity increased 0.73% to close at $31.65. Company weekly performance is -1.00% while its quarterly…
-
Stocks to Watch: Theravance Biopharma (NASDAQ:TBPH), 3D Systems Corporation (NYSE:DDD), Merrimack Pharmaceuticals (NASDAQ:MACK), Suburban Propane Partners (NYSE:SPH), Geospace Technologies (NASDAQ:GEOS)
Theravance Biopharma, Inc. (NASDAQ:TBPH) announced on 3 December through its U.S. operating subsidiary, Theravance Biopharma US, Inc., that stock options to purchase an aggregate of 104,800 of the Company’s ordinary shares were granted to ten new non-executive officer employees on December 1, 2014. Theravance Biopharma, Inc. (NASDAQ:TBPH) in last trading activity advanced 0.81% to close…
-
Top Stocks: Achillion Pharmaceuticals (NASDAQ:ACHN), Theravance Biopharma (NASDAQ:TBPH), Blackbaud Inc. (NASDAQ:BLKB), Healthcare Realty Trust Incorporated (NYSE:HR), NuVasive (NASDAQ:NUVA)
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) had its price target increased by Leerink Swann from $12.00 to $25.00 in a research report sent to investors on Tuesday morning. The firm currently has an outperform rating on the stock. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) in last trading activity increased 10.30% to close at $13.06. Company weekly performance is -8.03%…
-
Moving Stocks: Synthetic Biologics Inc. (NYSEMKT:SYN), Theravance Biopharma (NASDAQ:TBPH), Wyndham Worldwide Corporation (NYSE:WYN), Superior Energy Services (NYSE:SPN), FirstService Corporation (NASDAQ:FSRV)
Synthetic Biologics, Inc. (NYSEMKT:SYN) announced positive topline safety and tolerability results from a Phase 1a clinical trial of SYN-004, the Company’s investigational oral beta-lactamase enzyme for the prevention of Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy. Synthetic Biologics Inc. (NYSEMKT:SYN) in last trading…
-
Stock in News: Ennis Inc. (NYSE:EBF), Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Essex Property Trust Inc. (NYSE:ESS), Enable Midstream Partners (NYSE:ENBL), Theravance Biopharma (NASDAQ:TBPH)
Macquarie began coverage on shares of Ennis Inc. (NYSE:EBF) in a report released on Thursday, TheFlyOnTheWall.com reports. The firm issued an underperform rating on the stock. Ennis Inc. (NYSE:EBF) in last trading activity increased 5.37% to close at $13.94. Company weekly performance is 10.28% while its quarterly performance stands at 8.23%. Ennis Inc. (NYSE:EBF) is…
-
Whats Hot: Theravance Biopharma (NASDAQ:TBPH), Cherokee Inc. (NASDAQ:CHKE), Kyocera Corp. (NYSE:KYO), RGC Resources (NASDAQ:RGCO), Canadian Natural Resources Limited (NYSE:CNQ)
On 3 December Theravance Biopharma, Inc. (NASDAQ:TBPH) announced, through its U.S. operating subsidiary, Theravance Biopharma US, Inc., that stock options to purchase an aggregate of 104,800 of the Company’s ordinary shares were granted to ten new non-executive officer employees on December 1, 2014. The options were granted in accordance with NASDAQ Listing Rule 5635(c)(4) under…
-
5 Stock in Different Moves: Affimed N.V. (NASDAQ:AFMD), Theravance Biopharma (NASDAQ:TBPH), Quaker Chemical Corporation (NYSE:KWR), SIFCO Industries (NYSEMKT:SIF), Celldex Therapeutics (NASDAQ:CLDX)
Affimed N.V. (NASDAQ:AFMD) on 18 November reported Net income for the third quarter 2014 was EURO7.3 million or EURO2.17 per share, compared to a loss of EURO11.55 million or EURO40.36 per share for the third quarter 2013. Affimed N.V. (NASDAQ:AFMD) in last trading activity advanced 7.02% to close at $6.10. Company weekly performance is 13.38%…
-
Why These Are Hot: The KEYW Holding Corporation (NASDAQ:KEYW), Red Hat (NYSE:RHT), Cisco Systems (NASDAQ:CSCO), Theravance Biopharma (NASDAQ:TBPH), Retrophin (NASDAQ:RTRX)
KEYW Holding Corp. (NASDAQ:KEYW) has been given a consensus rating of “Hold” by the eight analysts that are covering the stock, AnalystRatings.NET reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company. On last trading day The…
-
Hot News: Sirius XM Holdings Inc. (NASDAQ:SIRI), Everyday Health (NYSE:EVDY), Resonant Inc. (NASDAQ:RESN), Synergy Pharmaceuticals (NASDAQ:SGYP), Theravance Biopharma (NASDAQ:TBPH)
Sirius XM Holdings Inc. (NASDAQ:SIRI) has agreed to pay back customers who complained they were deceived by the satellite radio company. Sirius XM Holdings Inc. (NASDAQ:SIRI) in last trading activity moved down -0.56% to close at $3.58. Company weekly performance is -0.56% while its quarterly performance stands at -0.56%. Sirius XM Holdings Inc. (NASDAQ:SIRI) is…